Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/18/2018
Start Date:June 2010
End Date:October 2014

Use our guide to learn which trials are right for you!

A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System

The purpose of this study is to conduct a pilot single-arm to assess transoral robotic
surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci
Robotic Surgical System.

Patients are going to be evaluated in their usual regular clinical follow ups starting with
preoperative first visit, 3 weeks, 3 months and 6 months postoperatively with a Quality of
Life survey (Head and Neck Cancer Inventory, HNCI-QOLQ).

Inclusion Criteria:

- Patient must present with indications for diagnostic or therapeutic approaches for
benign and malignant diseases of the oral cavity or laryngopharynx (including the
neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate,
posterior and lateral pharynx, glottic, supraglottic and subglottic larynx)

- Patients must have adequate transoral exposure of the oral cavity and laryngopharynx
for TORS instrumentation

Exclusion Criteria:

- Unexplained fever and/or untreated, active infection

- Patient pregnancy

- Previous head and neck surgery precluding transoral/robotic procedures

- The presence of medical conditions contraindicating general anesthesia or transoral
surgical approaches
We found this trial at
1
site
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
336-716-2011
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials